5//SEC Filing
Barrage Khalil 5
Accession 0001493152-20-002881
CIK 0001022899other
Filed
Feb 23, 7:00 PM ET
Accepted
Feb 24, 2:16 PM ET
Size
5.7 KB
Accession
0001493152-20-002881
Insider Transaction Report
Form 5
Barrage Khalil
Director
Transactions
- Purchase
Convertible Note
2019-11-05$50000.00/shExercise: $1.25From: 2019-11-05Exp: 2023-11-06→ Common stock, par value $0.0001 per share (40,000 underlying)
Footnotes (1)
- [F1]The reported transaction is the purchase of a convertible note, convertible at the holder's discretion at any time into common stock at the rate of $1.25 per share.
Documents
Issuer
Protagenic Therapeutics, Inc.\new
CIK 0001022899
Entity typeother
Related Parties
1- filerCIK 0001666011
Filing Metadata
- Form type
- 5
- Filed
- Feb 23, 7:00 PM ET
- Accepted
- Feb 24, 2:16 PM ET
- Size
- 5.7 KB